Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Evaluation of a Day Hospital Program for Adolescents and Young Adults With Eating Disorders (UDJ-TCA)

12 juin 2026 mis à jour par: Fondation Santé des Étudiants de France

Evaluation of the Contribution of a Specialized Day Hospital for Adolescents and Young Adults With Eating Disorders: Long-Term Clinical Outcomes and Cross-Reported Experiences

This study aims to evaluate the clinical, psychological, and functional outcomes of adolescents with anorexia nervosa receiving multidisciplinary care in hospital settings. Participants are treated either in a day hospitalization program or in a full-time inpatient program, in accordance with the French national guidelines (Haute Autorité de Santé, HAS) for the management of anorexia nervosa.

The study seeks to better understand the evolution of patients' health status over time, including nutritional, psychological, and social dimensions, and to identify factors associated with treatment response. Data will be collected as part of routine clinical care without modification of the standard therapeutic management.

The results of this study may help improve clinical practices and optimize care pathways for adolescents with anorexia nervosa.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Estimé)

307

Phase

  • N'est pas applicable

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant
  • Adulte

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Adolescents and young adults aged 12 to 22 years
  • Diagnosed with an eating disorder
  • Referred for admission to the day hospital program between October 2019 and December 2023
  • Provided informed consent (and parental consent for minors)

Exclusion Criteria:

  • Refusal to participate
  • Age below 12 years or above 22 years

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Non randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Autre: Day Hospital Program
Participants admitted to a specialized multidisciplinary day hospital program for eating disorders.
Participants admitted to the day hospital receive a multidisciplinary treatment program including psychiatric, medical, nutritional, and psychosocial care, delivered through structured daytime sessions without overnight stay.
Autre: Non-Admitted Participants
Participants who requested admission but were not admitted to the day hospital program.
Participants not admitted to the day hospital program receive usual care according to standard clinical pathways outside the specialized day hospital setting.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Délai
Change in Body Mass Index (BMI)
Délai: From admission request to at least 18 months follow-up
From admission request to at least 18 months follow-up

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change in eating disorder psychopathology assessed by EDE-Q
Délai: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Eating disorder psychopathology will be assessed using the Eating Disorder Examination Questionnaire (EDE-Q), a self-report scale ranging from 0 to 6, with higher scores indicating more severe symptoms. The assessment will be performed at admission and discharge.
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Change in body image concerns assessed by BSQ
Délai: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Body image concerns will be assessed using the Body Shape Questionnaire (BSQ), a self-report scale with higher scores indicating greater body dissatisfaction. The assessment will be performed at admission and discharge.
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Change in anxiety and depression symptoms assessed by HADS
Délai: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Anxiety and depression symptoms will be assessed using the Hospital Anxiety and Depression Scale (HADS), which includes subscales for anxiety and depression, each ranging from 0 to 21, with higher scores indicating greater symptom severity. The assessment will be performed at admission and discharge.
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Change in obsessive-compulsive symptoms assessed by MOCI
Délai: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Obsessive-compulsive symptoms will be assessed using the Maudsley Obsessive-Compulsive Inventory (MOCI), where higher scores indicate more severe symptoms. The assessment will be performed at admission and discharge.
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Change in eating disorder-related quality of life assessed by EDQoL
Délai: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Quality of life related to eating disorders will be assessed using the Eating Disorders Quality of Life (EDQoL) questionnaire, with higher scores indicating greater impairment. The assessment will be performed at admission and discharge
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Change in autistic traits assessed by AQ-10
Délai: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Autistic traits will be assessed using the Autism Spectrum Quotient (AQ-10), a brief screening tool with higher scores indicating more pronounced autistic traits. The assessment will be performed at admission and discharge
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Change in family functioning assessed by FAD-12
Délai: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission
Family functioning will be assessed using the Family Assessment Device (FAD-12), with higher scores indicating poorer family functioning. The assessment will be performed at admission and discharge.
Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

25 mai 2026

Achèvement primaire (Estimé)

24 février 2027

Achèvement de l'étude (Estimé)

24 février 2027

Dates d'inscription aux études

Première soumission

12 mai 2026

Première soumission répondant aux critères de contrôle qualité

12 juin 2026

Première publication (Réel)

15 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

15 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

12 juin 2026

Dernière vérification

1 juin 2026

Plus d'information

Termes liés à cette étude

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner